NovaBridge Biosciences (NBP)
$1.36+0.00%Close
SELLCRISIS · day 18
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $68M
- Beta
- 1.50
- P/E (TTM)
- -2.38
- Short % float
- 8.93%
- Days to cover
- 17.1
- SI change
- +4.5%
- 1W
- +0.00%
- 1M
- -24.44%
- vs SPY 1W
- -1.20%
- vs SPY 1M
- -24.91%
Industry peers
FMP comparable companies · ranked by market cap
- DRTSBUYAlpha Tau Medical Ltd$1.3BBEARQ 16$14.51+0.81%
- LBRXSELLLB Pharmaceuticals Inc Common Stock$1.1BCRISISQ 76$37.28-6.41%
- DSGNSELLDesign Therapeutics, Inc.$764MCRISISQ -12$12.24+0.65%
- ANNXSELLAnnexon, Inc.$675MRECOVERYQ -8$4.12+0.24%
- AURASELLAura Biosciences, Inc.$625MCRISISQ -6$6.04+2.13%
- ALTSELLAltimmune, Inc.$537MCRISISQ -5$2.76-2.55%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 17
- VALUE
- 19
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-0.9%
REV YoY-
ROE-1.4%
EPS YoY-
ROA-21.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-2.38
P/E FWD-
SECTOR PE20.58
INDUSTRY PE13.91
P/B0.78
P/FCF-
EV/EBITDA0.49
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.22
ALTMAN Z-
CURR RATIO7.64
ND/EBITDA-
BETA1.50
